AP Biosciences, Inc. (TPEX:6945)
Taiwan
· Delayed Price · Currency is TWD 186.00
-0.50 (-0.27%)
Apr 29, 2026, 11:56 AM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 15.96 billion as of April 28, 2026. Its market cap has increased by 249.05% in one year.
Market Cap
15.96B
Enterprise Value
14.85B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
186.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 15.96B, an increase of 213.20%. That is a compound annual growth rate of 50.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 16.30B | 6.41% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 15.88B |
| Medigen Vaccine Biologics | 15.65B |
| Polaris Group | 15.05B |
| EirGenix | 14.42B |
| TaiMed Biologics | 13.13B |
| Lumosa Therapeutics | 21.10B |
| Sunmax Biotechnology | 21.16B |
| CHO Pharma | 11.56B |